The MRI-based technique of quantitative susceptibility mapping can monitor iron levels in the brains of multiple sclerosis (MS) patients, allowing physicians to identify those at a higher risk of developing physical disability, according to a recent Radiology study.  

Siemens Healthineers is debuting the FlexForce Coach performance consulting and FlexForce Tech staffing solutions, which are designed to educate and improve the workflow of radiologic and laboratory technologists. FlexForce Coach and FlexForce Tech can help a health care organization transform its delivery of care and improve the patient experience.

CT use has risen over the past 20 years, and new research published in the Journal of the National Cancer Institute finds the modality may increase the risk of brain cancer, especially among children.

The U.S. House Appropriations Committee may further delay implementation of the 2009 U.S. Preventative Services Task Force (USPSTF) breast cancer screening recommendations another year with draft legislation approved July 12.

Newly engineered liposomes, or 'nano-bubbles,' can deliver chemotherapy drugs on-demand when activated by x-rays. They have proven to be successful in killing bowel cancer cells, according to the Center for Nanoscale BioPhotonics in Adelaide, Australia.

Microsoft co-founder Bill Gates joined a handful of wealthy donors, July 17, saying he will pledge more than $30 million over three years to advance research aimed at early Alzheimer’s detection.

Mailing colorectal cancer screening tests to Medicaid patients increased screening rates by roughly 10 percent—showing a more direct approach can improve results, according to research from the University of North Carolina (UNC) Comprehensive Cancer Center.

Technological advancements over the past three decades have placed 3D MRI on par with its 2D counterpart in depicting cartilage defects, according to a study published in Radiology. With specific alterations, the modality may be able to replace traditional MRI.

A new test that can diagnose chronic traumatic encephalopathy (CTE) in living patients with head trauma may pave the way for advances in diagnostic brain imaging, according to a July 18 article published by NPR.